Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Antitumor Agents 288: Design, Synthesis, SAR, And Biological Studies Of Novel Heteroatom-incorporated Antofine And Cryptopleurine Analogues As Potent And Selective Antitumor Agents.
X. Yang, Q. Shi, S. Yang, C. Chen, Sung-Liang Yu, K. Bastow, S. Morris-Natschke, P. Wu, Chin-Yu Lai, Tian-Shung Wu, Shiow-Lin Pan, Che-Ming Teng, Jau-Chen Lin, P. Yang, K. Lee
Published 2011 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Novel heteroatom-incorporated antofine and cryptopleurine analogues were designed, synthesized, and tested against a panel of five cancer cell lines. Two new S-13-oxo analogues (11 and 16) exhibited potent cell growth inhibition in vitro (GI(50): 9 nM and 20 nM). Interestingly, both compounds displayed improved selectivity among different cancer cell lines, in contrast to the natural products antofine and cryptopleurine. Mechanism of action (MOA) studies suggested that R-antofine promotes dysregulation of DNA replication during early S phase, while no similar effects were observed for 11 and 15 on corresponding replication initiation complexes. Compound 11 also showed greatly reduced cytotoxicity against normal cells and moderate antitumor activity against HT-29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.
This paper references
Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebine, and tubulosine.
R. Gupta (1977)
Inhibition of thymidylate synthase by pergularinine, tylophorinidine and deoxytubulosine.
K. N. Rao (1999)
In silico prediction of blood-brain barrier permeation.
D. Clark (2003)
Inhibition of thymidylate synthase and cell growth by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine.
K. N. Rao (1997)
Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids
C. Yang (2006)
Anti-inflammatory effects of 7-methoxycryptopleurine and structure-activity relations of phenanthroindolizidines and phenanthroquinolizidines.
C. Yang (2007)
Structural analogs of tylophora alkaloids may not be functional analogs.
W. Gao (2008)
Phenanthroquinolizidine alkaloids from the roots of Boehmeria pannosa potently inhibit hypoxia-inducible factor-1 in AGS human gastric cancer cells.
Xing Fu Cai (2006)
Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents.
K. N. Rao (2000)
Isolation, Total Synthesis and Biological Activity of Phenanthroindolizidine and Phenanthroquinolizidine Alkaloids
Z. Li (2004)
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
M. Alavijeh (2011)
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
L. Wei (2007)
Phenanthroindolizidines and Phenanthroquinolizidines: Promising Alkaloids for Anti-Cancer Therapy.
S. Chemler (2009)
The interaction between tylophorine B and TMV RNA.
Z. Xi (2006)
An antimicrobial alkaloid fromFicus septica
B. Baumgartner (1990)
Structural determinants responsible for the biological activity of (-)-emetine, (-)-cryptopleurine, and (-)-tylocrebrine: structure-activity relationship among related compounds.
R. Gupta (1980)
Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.
H. van de Waterbeemd (1998)
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
X. Yang (2009)
Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-kappaB pathways.
Jau-Chen Lin (2009)
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
W. Gao (2007)
Efficient Synthesis of Aza-Phenanthroindolizidine and Aza-Phenanthroquinolizidine and Anticancer Activities
K. Wang (2008)
C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties.
M. Banwell (2006)
Plant based antiamoebic drugs; Part I. Antiamoebic activity of phenanthroindolizidine alkaloids; common structural determinants of activity with emetine.
K. Bhutani (1987)
DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism
Y. Wang (2010)
Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis.
M. Huang (1972)
Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
J. Cusack (2000)
Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives.
K. Wang (2010)
Novel Mode of Action of Tylophorine Analogs as Antitumor Compounds
W. Gao (2004)
Antitumor agents. 274. A new synthetic strategy for E-ring SAR study of antofine and cryptopleurine analogues.
X. Yang (2010)
Quantitation of the specific interaction of [14a-3H]cryptopleurine with 80S and 40S ribosomal species from the yeast Saccharomyces cerevisiae.
H. Dölz (1982)
Anticancer agents based on natural product models
J. M. Cassady (1980)
The Indolizidine Alkaloids
E. Gellert (1982)
This paper is referenced by
Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs.
M. J. Niphakis (2012)
Synthesis of alkaloids: recent advances in the synthesis of phenanthroindolizidine alkaloids.
A. Burtoloso (2014)
Synthesis of indolizidinone analogues of cytotoxic alkaloids: monocyclic precursors are also active.
A. Boto (2012)
Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents
Y. Wang (2018)
Cryptopleurine Analogs with Modification of E Ring Exhibit Different Mechanism to Rac-Cryptopleurine and Tylophorine
Y. Wang (2012)
Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
Ziwen Wang (2012)
The Reactivity of Enantiopure (S)‐6‐Oxopipecolic Acid and Corresponding Pyridoisoquinolines Under Acidic Conditions
P. Šafár̆ (2018)
Antofine-induced connexin43 gap junction disassembly in rat astrocytes involves protein kinase Cβ.
Y. Huang (2013)
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
X. Yang (2012)
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
Yongseok Kwon (2015)
J. H. Ryan (2011)
Total synthesis of phenanthroindolizidine alkaloids through an amidyl radical cascade/rearrangement reaction.
G. Han (2013)
First Discovery of Tylophora Alkaloids as HIV Inhibitors
Ziwen Wang (2015)
Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies.
N. P. Kumar (2018)
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
M. Wu (2013)
Synthesis of 2,3,6,7-tetramethoxyphenanthren-9-amine: An efficient precursor to access new 4-aza-2,3-dihydropyridophenanthrenes as apoptosis inducing agents.
N. P. Kumar (2017)
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.
N. P. Kumar (2017)
Antofine Analogues Can Inhibit Tobacco Mosaic Virus Assembly through Small‐Molecule–RNA Interactions
S. Gao (2012)
Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies.
N. P. Kumar (2017)
Use of chiral-pool approach into epi-thieno analogues of the scarce bioactive phenanthroquinolizidine alkaloids
P. Šafár̆ (2016)
Simplification of antitumoral phenanthroindolizidine alkaloids: short synthesis of cytotoxic indolizidinone and pyrrolidine analogs.
J. Miguélez (2013)
Optimization of on-line solid phase extraction and HPLC conditions using response surface methodology for determination of WM-5 in mouse plasma and its application to pharmacokinetic study.
L. Liu (2013)
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Wenda Zhang (2018)
Microwave-assisted one-pot synthesis of new phenanthrene fused-tetrahydrodibenzo-acridinones as potential cytotoxic and apoptosis inducing agents.
N. P. Kumar (2018)
Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives.
Anilkumar S. Patel (2020)
The use of natural products in colorectal cancer drug discovery
K. Miura (2015)
Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years.
Hongyu Tao (2020)
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
Yongseok Kwon (2013)
Reliability of Click Chemistry on Drug Discovery: A Personal Account.
N. Shankaraiah (2019)